Joanne L Billings – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emailbilli001umnedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

13 Active
46 Finished

13 results

Filter

Active
A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacyand Safety of VX-121Combination Therapy in Subjects With Cystic FibrosisWho Are Heterozygous for F508del and a Minimal Function Mutation (F/MF)
Billings, J. L.
Vertex Pharmaceuticals Incorporated
9/1/21 → 9/1/23
Project: Research project
MAYFLOWERS-0B-20: A Prospective Study Evaluating Maternal and FetaL Outcomes in the ERa of ModulatorS (MAYFLOWERS)
Billings, J. L.
Seattle Children's Hospital
4/1/21 → 4/1/25
Project: Research project
Collaborative Cohort of Cohorts for COVID-19 Research (C4R)
Billings, J. L.
National Jewish Health
3/3/21 → 5/31/22
Project: Research project
Optimal vancomycin exposure target for pulmonary exacerbations in CF
Illamola, S. M., Billings, J. L., Evans, M. D. & Hirsch, E. B.
Cystic Fibrosis Foundation
1/1/21 → 12/31/22
Project: Research project
SIMPLIFY-IP-19: A protocol to test the impact of discontinuing chronic therapies in people with cystic fibrosis on highly effective CFTR modulator therapy (SIMPLIFY)
Billings, J. L.
Seattle Children's Hospital
1/1/20 → 12/31/22
Project: Research project
A Phase 3, Open-label Study Evaluating the Long-term Safety of VX-445 Combination Therapy in Subjects With Cystic Fibrosis
Billings, J. L.
Vertex Pharmaceuticals Incorporated
7/30/19 → 7/30/22
Project: Research project
A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)
Billings, J. L.
Vertex Pharmaceuticals Incorporated
7/30/19 → 8/1/22
Project: Research project
A Phase 2, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of VX-561 in Subjects aged 18 Years and Olderwith Cystic Fibrosis
Billings, J. L.
Vertex Pharmaceuticals Incorporated
6/1/19 → 7/31/22
Project: Research project
PROMISE-OB-18, A prospective study to evaluate biological and clinical effects of significantly correctedCFTR function (the PROMISE Study) (Pro00029275)
Billings, J. L.
Seattle Children's Hospital
11/1/18 → 5/1/23
Project: Research project
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)
Blazar, B. R., AbuSalah, A. M., Adam, T. J., Aliferis, MD, PhD, C., Allen, J., Beckman, K. B., Billings, J. L., Bloomfield, H. E., Bornsztein, B., Brearley, A. M., Call, K. T., Chi, C., Clancy, T. R., Connett, J. E., Daniels, B. S., Eder, M., El-Fakahany, E. E., Fischer, G., Fulkerson, J., Garwood, M., Georgopoulos, A. P., Guan, W., Henderson, J. N., Hodges, J. S., Ingbar, D. H., Jones-Webb, R. J., Jordan, C., Karypis, G., Knights, D., Kumar, V., LeBien, T. W., Lim, K. O., Ma, S., Melton-Meaux, G. B., Myers, C. L., Neuhauser, C., Oakes, M., Okuyemi, K., Pakhomov, S. V., Panoskaltsis-Mortari, A., Pieczkiewicz, D. S., Raymond, N. C., Riggs, S., Rudser, K., Ruggles, S., Schacker, T. W., Schleiss, M. R., Shekhar, S., Shen, S., Simon, G. J., Ugurbil, K., Vock, D. M., Volkov, B. B., Wang, J., Warren, R., Weber-Main, A. M., Weisdorf, D. J., Wolf, S. M., Zellmer-Bruhn, M. E. & Zhang, R.
NIH NAT'L CTR FOR ADVANCING TRAN SCIENCE
3/30/18 → 2/28/23
Project: Research project
CHEC-OB-17 CHaractErizing CFTR Modulated Changes in
Billings, J. L.
Seattle Children's Hospital
7/1/17 → 6/1/23
Project: Research project
Genetic Epidemiology of COPD
Billings, J. L.
National Jewish Health
1/1/13 → 7/31/22
Project: Research project
A Long-Term Prospective Observational Study of the Incid
Billings, J. L.
Cystic Fibrosis Foundation
6/1/12 → 6/1/23
Project: Research project